Format

Send to

Choose Destination
Histol Histopathol. 2018 Jul;33(7):619-627. doi: 10.14670/HH-11-942. Epub 2017 Nov 2.

Current status of bone regeneration using adipose-derived stem cells.

Author information

1
Department of Plastic and Reconstructive Surgery, Juntendo University School of Medicine, Tokyo, Japan.
2
Department of Dentistry and Oral Surgery, AOI Universal Hospital, Kanagawa, Japan.
3
Department of Plastic and Reconstructive Surgery, Juntendo University School of Medicine, Tokyo, Japan. hmizuno@juntendo.ac.jp.

Abstract

Many bone regeneration therapies have been developed for clinical use and have variable outcomes and serious limitations. The goal of bone regeneration is to repair a bone defect in a stable and durable manner. Cellular strategies play an important role in bone tissue engineering. Clinical factors important for successful bone regeneration are the recruitment of cells to the defect site and the production of a suitable extracellular matrix consistent with bone tissues. Adipose-derived stem cells (ASCs) can be obtained in large quantities with little donor site morbidity or patient discomfort. They are multipotent somatic stem cells and have a strong potential to differentiate and secrete growth factors. In this review, we discuss the osteogenic potential of ASCs with/without several types of scaffolds in vivo and their clinical application for bone regeneration.

PMID:
29094748
DOI:
10.14670/HH-11-942
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Sercrisma International S.L.
Loading ...
Support Center